دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Exploring new frontiers: Effects of psychedelics on neurotransmitter-regulated glucagon release in pancreatic islets
Mehmet Bostancıklıoğlu PhD
doi : 10.1111/dom.15411
Suicidality among users of glucagon-like peptide-1 receptor agonists: An emerging signal?
Darren Lau MD, John-Michael Gamble PhD
doi : 10.1111/dom.15459
The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review
Lance Sloan MD, Alice Y. Y. Cheng MD, Javier Escalada MD, Martin HaluzÃk MD, Didac Mauricio MD
doi : 10.1111/dom.15425
Treatment effect of semaglutide 2.4 mg on health-related quality of life from STEP 1 SF-6D derived from SF-36 with Australian weights
Pavol Kral PhD, Felicity Liza Allen MPH, Sara Larsen MSc, Thomas Holst-Hansen PhD, Anamaria-Vera Olivieri MSc, Andrew Manton MEpi
doi : 10.1111/dom.15426
Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial
Tali Cukierman-Yaffe MD, Chinthanie Ramasundarahettige MSc, Jackie Bosch PhD, Hertzel C. Gerstein MD
doi : 10.1111/dom.15412
Influence of a diet and/or exercise intervention on long-term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study
Liping Yu MD, Jinping Wang MD, Qiuhong Gong MD, Yali An MD, Fei Chen PhD, Yanyan Chen MD, XiaoPing Chen MD, Siyao He MD, Xin Qian MD, Bo Chen PhD, Fen Dong PhD, Hui Li MD, Fang Zhao MD, Bo Zhang MD, Guangwei Li MD, for the Da Qing Diabetes Prevention Study Group … See fewer authorsÂ
doi : 10.1111/dom.15413
Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan-O-AP and LixiLan-L-CN trials
Wenying Yang MD, Xiaohui Guo MD, Felipe Lauand MD, Lingyu Li MS, Hexin Fang MD, Qin Du MD, Lei Kang MD
doi : 10.1111/dom.15414
Impact of the diagnosis of gestational diabetes on maternal physical activity after pregnancy
Sadia Mehmood MD, Chang Ye MSc, Anthony J. Hanley PhD, Philip W. Connelly PhD, Mathew Sermer MD, Bernard Zinman MD, Ravi Retnakaran MD
doi : 10.1111/dom.15415
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial
Hertzel C. Gerstein MD, Rajibul Mian PhD, Chinthanie Ramasundarahettige MSc, Kelley R. H. Branch MD, Stefano Del Prato MD, Carolyn S. P. Lam MBBS, Renato D. Lopes MD, Richard Pratley MD, Julio Rosenstock MD, Naveed Sattar MD … See fewer authorsÂ
doi : 10.1111/dom.15417
Efficacy and safety of intragastric expandable oral capsules in adults with overweight or obesity: A randomized, double-blind, placebo-controlled trial
Difei Lu MD, Zhenfang Yuan MD, Xiaohui Guo PhD, Liyong Zhu PhD, Fan Zhang PhD, Xuejun Li PhD, Wenbo Wang PhD, Huandong Lin PhD, Jingnan Luo PhD
doi : 10.1111/dom.15418
Patterns of metformin use and glycated haemoglobin trends among patients with newly diagnosed type 2 diabetes in Alberta, Canada
Tina Kim MD, Dennis B. Campbell BSc, Flora Au MA, Paul E. Ronksley PhD, Robert G. Weaver MSc, David J. T. Campbell MD
doi : 10.1111/dom.15419
Reduced incidence of diabetes during the COVID-19 pandemic in Alberta: A time-segmented longitudinal study of Alberta's Tomorrow Project
Ming Ye PhD, Jennifer E. Vena PhD, Grace Shen-Tu PhD, Jeffrey A. Johnson PhD, Dean T. Eurich PhD
doi : 10.1111/dom.15420
Elucidating the glucose-lowering effect of the bile acid sequestrant sevelamer
Henriette H. Nerild MD, Andreas Brønden MD, Abdullah E. Haddouchi MD, Anne-Marie Ellegaard PhD, Bolette Hartmann PhD, Jens F. Rehfeld MD, Jens J. Holst MD, David P. Sonne MD, Tina Vilsbøll MD, Filip K. Knop MD … See fewer authorsÂ
doi : 10.1111/dom.15421
Associations between Chinese visceral adiposity index and risks of all-cause and cause-specific mortality: A population-based cohort study
Xiaoyan Wu MM, Chunqi Wang BMS, Deliang Lv MM, Bowang Chen PhD, Yi Wu BM, Xiaobing Wu PhD, Yang Yang MS, Jianlan Cui MSPM, Wei Xu MPH, Hao Yang BS, Lijuan Song MS, Wenyan He BS, Yan Zhang BS, Hongyun Guan MM, Fengzhu Xie MM, Wei Xie MM, Qinggang Shang MM, Zhiguang Zhao PhD, Xi Li PhD
doi : 10.1111/dom.15424
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease
Jinnie J. Rhee ScD, Jialin Han MS, Maria E. Montez-Rath PhD, Glenn M. Chertow MD
doi : 10.1111/dom.15427
Validation of an international classification of disease, tenth revision, clinical modification (ICD-10-CM) algorithm in identifying severe hypoglycaemia events for real-world studies
Qoua L. Her PharmD, Sara Z. Dejene MSPH, Sherin Ismail PharmD, Tiansheng Wang PhD, Michele Jonsson-Funk PhD, Virigina Pate MS, Jea Young Min PhD, James Flory MD
doi : 10.1111/dom.15428
Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Post-authorization safety study based on multinational cohorts
Cristina Rebordosa MD, Reimar W. Thomsen MD, Arlene K. Tave MA, Morten Madsen MSc, Daniel C. Beachler PhD, David Martinez MSc, Raquel Garcia-Esteban MSc, Estel Plana MSc, Anita Tormos MPH, Soulmaz Fazeli Farsani PharmD, Susana Perez-Gutthann MD, Manel Pladevall-Vila MD … See fewer authorsÂ
doi : 10.1111/dom.15429
Real-world use of glucagon-like peptide-1 receptor agonists in youth with type 2 diabetes is associated with short-term improvements in HbA1c
Stephanie L. Samuels MD, Anastasia Chajecki BSc, Pamela Hu MD, Michelle Kayser MD, Kate Weyman APRN, Bernard Pan BS, Elizabeth A. Brown MPH, Michelle Van Name MD, Risa M. Wolf MD
doi : 10.1111/dom.15430
Glucose sensor with predictive alarm for hypoglycaemia: Improved glycaemic control in adolescents with type 1 diabetes
Marco Marigliano MD, Claudia Piona MD, Valentina Mancioppi MD, Elisa Morotti MD, Anita Morandi MD, Claudio Maffeis MD
doi : 10.1111/dom.15432
Prusogliptin (DBPR108) monotherapy in treatment-naïve patients with type 2 diabetes: A randomized, double-blind, active and placebo-controlled, phase 3 study
Wei Wang MD, Xiaohui Guo MD, Cheng Zhang MD, Tao Ning MD, Guoqing Ma MD, Yanli Huang BSc, Rui Jia BSc, Deai Zhou BSc, Mengya Cao BSc, Tianhao Zhang MD, Lingli Yao MSc, Jing Yuan MD, Ling Chen BSc, DBPR108 monotherapy phase 3 study collaborative group … See fewer authorsÂ
doi : 10.1111/dom.15433
Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study
Harshal Deshmukh PhD, Kazeem Adeleke PhD, Emma G. Wilmot PhD, Anna Folwell MRCP, Dennis Barnes FRCP, Neil Walker MRCP, Simon Saunders MRCP, Emmanuel Ssemmondo MRCP, Chris Walton FRCP, Jane Patmore MRCP, Robert E. J. Ryder MD, Thozhukat Sathyapalan FRCP … See fewer authorsÂ
doi : 10.1111/dom.15434
Effect of intermittently scanned continuous glucose monitoring in people with diabetes with a psychosocial indication for initiation
Emmanuel Ssemmondo MRCP, Harshal Deshmukh PhD, Emma G. Wilmot PhD, Kazeem A. Adeleke PhD, Najeeb Shah MRCP, Chris Walton FRCP, Dennis Barnes FRCP, Robert E. J. Ryder FRCP, Thozhukat Sathyapalan FRCP
doi : 10.1111/dom.15435
Adherence to liraglutide among individuals with overweight and obesity: Patient characteristics and clinical measures
Amit Guy RN, Abed N. Azab PhD, Idit F. Liberty MD, Zaid Afawi MD, Ali Alhoashla MD, Muhammad Abu Tailakh PhD
doi : 10.1111/dom.15436
Twenty-four-hour physical behaviour profiles across type 2 diabetes mellitus subtypes
Joseph Henson PhD, Aikaterina Tziannou MSc, Alex V. Rowlands PhD, Charlotte L. Edwardson PhD, Andrew P. Hall FFICM, Melanie J. Davies MD, Thomas Yates PhD
doi : 10.1111/dom.15437
Pre-exercise protein intake is associated with reduced time in hypoglycaemia among adolescents with type 1 diabetes
Franklin R. Muntis PhD, Jamie L. Crandell PhD, Kelly R. Evenson PhD, David M. Maahs PhD, Michael Seid PhD, Saame R. Shaikh PhD, Abbie E. Smith-Ryan PhD, Elizabeth Mayer-Davis PhD
doi : 10.1111/dom.15438
First-in-human study of CPL207280, a novel G-protein-coupled receptor 40/free fatty acid receptor 1 agonist, in healthy volunteers after single and multiple administration
Katarzyna Bazydło-Guzenda PhD, Katarzyna Jarus-Dziedzic PhD, Agnieszka Gierczak-Pachulska PhD, Paweł Buda PhD, Piotr J. Rudzki DSc, Katarzyna Buś-Kwaśnik PhD, Ewelina Juszczyk PhD, Ewa Tratkiewicz PhD, Daniel Rabczenko PhD, Agnieszka Segiet-Święcicka PhD, Maciej Wieczorek PhD
doi : 10.1111/dom.15439
Socio-economic disparities in hospital care among Dutch patients with diabetes mellitus
Silvia A. G. de Vries MD, Theo C. J. Sas MD, Jessica C. G. Bak MD, Dick Mul MD, Max Nieuwdorp MD, Michel W. J. M. Wouters MD, Carianne L. Verheugt MD
doi : 10.1111/dom.15440
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study
Gui-Ling Chen MD, Yang Liu MD, Xue-Feng Gao BM, Kai-Qi Wu MD, Yun-Kai Yang MD, Yong Chen PhD, Cong-Gao Peng MD, Ting-Han Jin BM, Yu-Bao Huang PhD, Yao-Wen Zhang MD, Jing Su PhD, Qi Jiang BM, Tong Guo BM, Jie Zhao MD, Xiang-Nan Peng BM, Jing-Yu Peng MD, Si-Xiu Li MD, Yong-Li Sun BM, Hong-Mei Zhang MD, Yan-Li Fu MD, Dan Luo MSc, Yaru Ma BM, Zhen-Wei Shen PhD, Yun-Tao Zhang PhD, Zhang-Fei Shou PhD … See fewer authorsÂ
doi : 10.1111/dom.15441
REduced-Carbohydrate intervention for managing Obesity and Reduction of gestational Diabetes (RECORD): A randomized controlled feasibility trial
Moscho Michalopoulou PhD, Susan A. Jebb PhD, Lucy H. MacKillop MA (Oxon.), Pamela Dyson PhD, Jane E. Hirst PhD, Sufen Zhu MPhil, Amy Wire PPI, Nerys M. Astbury PhD
doi : 10.1111/dom.15442
Risk factor control and incident cardiovascular disease in patients with diabetes: Sex-specific relations
Xuan Wang MD, Hao Ma MD, Xiang Li MD, Zhaoxia Liang MD, Vivian Fonseca MD, Lu Qi MD
doi : 10.1111/dom.15443
Remodelling the inguinal adipose sensory system to switch on the furnace: Electroacupuncture stimulation induces brown adipose thermogenesis
Mengjiang Lu PhD, Ziwei Yu MD, Xingyu Yang MD, Li An PhD, Xinyue Jing PhD, Tiancheng Xu PhD, Mengqian Yuan PhD, Bin Xu PhD, Zhi Yu PhD
doi : 10.1111/dom.15444
Sex- and time-specific associations of obesity with glycaemic traits: A two-step multivariate Mendelian randomization study
Ye Tian BMSc, Guochen Ma BMSc, Jing Zi BMSc, Yifan Hu BMSc, Yaxian Zeng BMSc, Haoqi Li BMSc, Hang Luo BMSc, Shufang Shan MPH, Jingyuan Xiong PhD, Guo Cheng PhD
doi : 10.1111/dom.15445
Efficacy and safety of tirzepatide in people with type 2 diabetes by baseline body mass index: An exploratory subgroup analysis of SURPASS-AP-Combo
Jianhua Ma MD, Ming Liu MD, Rui Wang MD, Liying Du MS, Linong Ji MD
doi : 10.1111/dom.15446
Counting the lifetime cost of obesity: Analysis based on national England data
Adrian Heald DM, Michael Stedman BSc, Anthony A. Fryer PhD, Mark B. Davies MD, Martin K. Rutter PhD, J. Martin Gibson PhD, Martin Whyte PhD
doi : 10.1111/dom.15447
Adaptive infusion of a glucagon-like peptide-1/glucagon receptor co-agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial
David C. D. Hope MBBS, Saleem Ansari MB ChB, Sirazum Choudhury MBBS, Kleopatra Alexiadou MD, Yasmin Tabbakh MB ChB, Ibiyemi Ilesanmi MBBS, Katharine Lazarus MB ChB, Iona Davies MRes, Lara Jimenez-Pacheco DIPHS, Wei Yang MD, Laura-Jayne Ball BSc, Reshma Malviya PhD, Beata Reglinska MSc, Bernard Khoo PhD, James Minnion PhD, Stephen R. Bloom MD, Tricia M.-M. Tan MB ChB
doi : 10.1111/dom.15448
Two years with GIOIA ‘Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes’: A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice
Miriam Longo MD, Paola Caruso MD, Lorenzo Scappaticcio MD, Maria Ida Maiorino MD, Giuseppe Bellastella MD, Annalisa Capuano MD, Katherine Esposito MD, Dario Giugliano MD
doi : 10.1111/dom.15451
Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post-hoc machine learning analysis of ACCORD trial data
Tianze Jiao PhD, Hamed Kianmehr PhD, Yilu Lin PhD, Piaopiao Li MS, Naykky Singh Ospina MD, Hans K. Ghayee DO, Mohammed Ruzieh MD, Vivian Fonseca MD, Lizheng Shi PhD, Ping Zhang PhD, Hui Shao PhD
doi : 10.1111/dom.15453
Sodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database
Ryoichi Ishibashi MD, Yosuke Inaba PhD, Masaya Koshizaka MD, Yoko Takatsuna MD, Tomoaki Tatsumi MD, Yuki Shiko ME, Yusuke Kashiwagi MD, Yoshiro Maezawa MD, Yohei Kawasaki PhD, Eiryo Kawakami MD, Shuichi Yamamoto MD, Koutaro Yokote MD
doi : 10.1111/dom.15454
Real-world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study (ENDO2S-RWD)
Oscar Moreno-Pérez MD, Rebeca Reyes-Garcia MD, Inés Modrego-Pardo MD, Viyey Kishore Doulatram-Gamgaram MD, Carlos Casado Cases MD, Cristina Guillen-Morote MD, Nieves Arias Mendoza MD, Cristina Tejera-Pérez MD, Jersy Cárdenas-Salas MD, Sandra MartÃnez-Fuster MD, Beatriz Lardiés-Sánchez MD, Rosa Márquez-Pardo MD, Pedro Pinés MD, José Carlos Fernández-GarcÃa MD, on behalf of The SEEN Diabetes Area … See fewer authorsÂ
doi : 10.1111/dom.15431
The efficacy of glucose-responsive insulin and glucagon delivery on exercise-induced hypoglycaemia among adults with type 1 diabetes mellitus: A meta-analysis of randomized controlled trials
Mengyun Lei MD, Ping Ling MD, Ying Ni MM, Danrui Chen MM, Chaofan Wang MD, Daizhi Yang MD, Xubin Yang MD, Wen Xu MD, Jinhua Yan MD
doi : 10.1111/dom.15422
Obesity management from the perspectives of people living with obesity in Canada: A mixed-methods study
David C. W. Lau MD, Ian Patton PhD, Reena Lavji MPharm, Adel Belloum MD, Ginnie Ng PhD, Renuca Modi MD
doi : 10.1111/dom.15455
Effect of baseline characteristics on the efficacy of dulaglutide added to basal insulin in Chinese patients with type 2 diabetes: A subgroup analysis of AWARD-CHN3
Guoyu Tong MD, Song Lu MD, Hongyu Kuang MD, Yan Li MD, Yuying Deng MD, Ying Lou PhD, Weimin Wang MD, Dalong Zhu MD
doi : 10.1111/dom.15416
Taste perception genomics in gestational diabetes mellitus: A systematic review
Vishnu Shivam MBBS, Clare L. Gillies PhD, Louise M. Goff PhD, Francesco Zaccardi PhD, Kamlesh Khunti FMedSci
doi : 10.1111/dom.15449
Defining diabetes status using medication groups in Medicare data: Trends in prescribing diabetes medications to patients without a diabetes diagnosis over time
Carrie R. Howell PhD, Sha Zhu PhD, Gargya Malla PhD, Gargya Carson PhD, Doyle Cummings MD, Jalal Uddin PhD, Emily B. Levitan PhD, Monika Safford MD, Andrea L. Cherrington MD, D. Leann Long PhD
doi : 10.1111/dom.15450
Correction to ‘Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10-year forecasting model’
doi : 10.1111/dom.15452
